Feds join lawsuits claiming Insys used strip club visits, super-doses and more to boost Subsys sales
https://www.fiercepharma.com/pharma/doj-joins-whistleblower-suits-against-insys-over-alleged-opioid-kickback-scheme
Feds join lawsuits claiming Insys used strip club visits, super-doses and more to boost Subsys sales
by Arlene Weintraub | May 15, 2018 11:51am
Prosecutors have already charged Insys founder John Kapoor and won guilty pleas from two characters in an ongoing kickbacks probe. Now, the Justice Department has escalated the case by joining in with whistleblowers who've detailed a stunning range of techniques the company allegedly used to push its powerful opioid painkiller. The DOJ is allying with a half-dozen whistleblowersamong them former Insys employees and workers at a pharmacy benefits managerwho allege the company violated the federal False Claims Act by marketing Subsys for unapproved uses and using free dinners and entertainment to persuade doctors to prescribe more of its fentanyl nasal spray.
(snip)
The governments newly unmasked case alleged that starting in 2012, Insys operated a sham speaking program, paying physicians to talk about Subsys to healthcare professionals. In reality, the suit alleges, the speeches didnt include substantive information about the drug.
(snip)
The court document goes on to lay out the types of kickbacks Insys allegedly provided, including visits to strip clubs, lavish dining and entertainment outings and jobs for relatives and friends of people who prescribed Subsys. It details the actions of more than 19 prescribers and Insys sales representatives, including some who have been convicted for their roles in the companys alleged kickback schemes.
(snip)
The case against Insys revolves around allegations that the company marketed Subsys to treat many types of pain, though it was only FDA-approved for cancer pain. The DOJs lawsuit offers examples of Insys training sales representatives to pitch the product for those off-label uses.
(snip)
Most of the patients who received Subsys prescriptions weren't cancer patients, the lawsuit alleged. The government is seeking reimbursement for Medicare spending on scripts for patients who shouldnt have been covered, as well as recovery of all monies by which Insys has been unjustly enriched.
(snip)
((cross-post from GD))